Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation

被引:79
作者
Furgeson, Seth B. [1 ]
Simpson, Peter A. [1 ]
Park, Insun [1 ]
VanPutten, Vicki [1 ]
Horita, Henrick [1 ]
Kontos, Christopher D. [4 ]
Nemenoff, Raphael A. [1 ,2 ,3 ]
Weiser-Evans, Mary C. M. [1 ,2 ,3 ]
机构
[1] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
[2] Univ Colorado Denver, Div Cardiovasc, Aurora, CO 80045 USA
[3] Univ Colorado Denver, Dept Med, Pulm Res Program, Aurora, CO 80045 USA
[4] Duke Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
Vascular biology; NF-kappa B; Vascular injury; Vascular smooth muscle; Cytokines; chemokines; NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CELL-PROLIFERATION; GENE-EXPRESSION; ATHEROSCLEROSIS; ACTIVATION; INHIBITION; HYPERPLASIA; RECRUITMENT; RESTENOSIS;
D O I
10.1093/cvr/cvp425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Phosphatase and tensin homolog (PTEN) is implicated as a negative regulator of vascular smooth muscle cell (SMC) proliferation and injury-induced vascular remodelling. We tested if selective depletion of PTEN only in SMC is sufficient to promote SMC phenotypic modulation, cytokine production, and enhanced neointima formation. Smooth muscle marker expression and induction of pro-inflammatory cytokines were compared in cultured SMC expressing control or PTEN-specific shRNA. Compared with controls, PTEN-deficient SMC exhibited increased phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signalling and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activity, reduced expression of SM markers (SM-alpha-actin and calponin), and increased production of stromal cell-derived factor-1 alpha (SDF-1 alpha), monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and chemokine (C-X-C motif) ligand 1 (KC/CXCL1) under basal conditions. PI3K/Akt or mTOR inhibition reversed repression of SM marker expression, whereas PI3K/Akt or NF-kappa B inhibition blocked cytokine induction mediated by PTEN depletion. Carotid ligation in mice with genetic reduction of PTEN specifically in SMC (SMC-specific PTEN heterozygotes) resulted in enhanced neointima formation, increased SMC hyperplasia, reduced SM-alpha-actin and calponin expression, and increased NF-kappa B and cytokine expression compared with wild-types. Lesion formation in SMC-specific heterozygotes was similar to lesion formation in global PTEN heterozygotes, indicating that inactivation of PTEN exclusively in SMC is sufficient to induce considerable increases in neointima formation. PTEN activation specifically in SMC is a common upstream regulator of multiple downstream events involved in pathological vascular remodelling, including proliferation, de-differentiation, and production of multiple cytokines.
引用
收藏
页码:274 / 282
页数:9
相关论文
共 45 条
[1]   The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin [J].
Agarwal, A ;
Das, K ;
Lerner, N ;
Sathe, S ;
Cicek, M ;
Casey, G ;
Sizemore, N .
ONCOGENE, 2005, 24 (06) :1021-1031
[2]   The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis [J].
Bourcier, T ;
Sukhova, G ;
Libby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) :15817-15824
[3]   Chemokines in the pathogenesis of vascular disease [J].
Charo, IF ;
Taubman, MB .
CIRCULATION RESEARCH, 2004, 95 (09) :858-866
[4]   Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits - PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration [J].
Chen, WJ ;
Lin, KH ;
Lai, YJ ;
Yang, SH ;
Pang, JHS .
CIRCULATION, 2004, 110 (10) :1313-1319
[5]   NF-κB:: pivotal mediator or innocent bystander in atherogenesis? [J].
Collins, T ;
Cybulsky, MI .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :255-264
[6]   PTEN, a unique tumor suppressor gene [J].
Dahia, PLM .
ENDOCRINE-RELATED CANCER, 2000, 7 (02) :115-129
[7]   Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-κB) [J].
Dwarakanath, RS ;
Sahar, S ;
Reddy, MA ;
Castanotto, D ;
Rossi, JJ ;
Natarajan, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (04) :585-595
[8]   Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting Stents attenuates in-stent stenosis in rabbits and monkeys [J].
Egashira, Kensuke ;
Nakano, Kaku ;
Ohtani, Kisho ;
Funakoshi, Kouta ;
Zhao, Gang ;
Ihara, Yoshiko ;
Koga, Jun-Ichiro ;
Kimura, Satoshi ;
Tominaga, Ryuji ;
Sunagawa, Kenji .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (12) :2563-2568
[9]   Anti-monocyte chemoattractant protein-1 monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries [J].
Furukawa, Y ;
Matsumori, A ;
Ohashi, N ;
Shioi, T ;
Ono, K ;
Harada, A ;
Matsushima, K ;
Sasayama, S .
CIRCULATION RESEARCH, 1999, 84 (03) :306-314
[10]   Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN [J].
Garl, PJ ;
Wenzlau, JM ;
Walker, HA ;
Whitelock, JM ;
Costell, M ;
Weiser-Evans, MCM .
CIRCULATION RESEARCH, 2004, 94 (02) :175-183